德琪医药-B 港股通 空最新回购 (2026-07-21) 官网 ( 06996.hk) | -10.44 | 3.89 | 0% | 上市时间2020-11-20股价4.09港币涨跌幅1.24%成交金额327.82万港币换手率0.12%市值27.79亿港币H股市值27.79亿港币总股本6.79亿H股本6.79亿每手股数500上市至今年化投资收益率-23.05%港股通持仓占H股比例1.40% (3,836.18万港币2026-07-22) 累计做空占H股比例0.91% (2,529.00万港币2026-07-17) | |||
| 所属三级行业药品 (恒生) | 市盈率 | 27.47 | 市净率 | 2.47 | 股息率 | 1.38% | 恒生:医疗保健业药品及生物科技药品 |
| 备注 (2): | 双击编辑备注 |
德琪医药-B(06996) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | FONSECA Rafael | Independent Non Executive Director | 2023-04-14 | -- | |
| 2 | 劉逸倫 | Non Executive Director | 2021-12-16 | 2023-04-14 | |
| 3 | 龍振國 | Executive Director | 2021-06-18 | -- | |
| 4 | LYNCH Kevin Patrick | Executive Director | 2021-06-18 | 2022-12-16 | |
| 5 | 陳侃 | Non Executive Director | 2021-03-26 | -- | |
| 6 | 錢晶 | Independent Non Executive Director | 2020-11-09 | -- | |
| 7 | 唐晟 | Independent Non Executive Director - A/F | 2020-11-09 | -- | |
| 8 | CHIN John Francis | Executive Director | 2020-08-18 | -- | |
| 9 | ALLES Mark John | Independent Non Executive Director | 2020-01-02 | 2023-04-14 | |
| 10 | 曹彥凌 | Non Executive Director | 2019-02-04 | 2021-12-16 | |
| 11 | 李甄 | Non Executive Director | 2019-02-04 | 2021-06-18 | |
| 12 | 劉翼騰 | Executive Director | 2018-11-22 | 2021-06-18 | |
| 13 | 胡旭波 | Non Executive Director | 2018-11-22 | 2021-03-26 | |
| 14 | 梅建明 | Executive Director | Chairman, CEO | 2018-08-28 | -- |